Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-10-21

AUTHORS

Esther H. Bae, Mark K. Greenwald, Ann G. Schwartz

ABSTRACT

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious and often persistent adverse consequence of certain chemotherapeutic agents. It is a major dose-limiting factor of many first-line chemotherapies, affecting 20–50% of patients at standard doses and nearly all patients at high doses. As cancer survivorship continues to increase with improvements in early diagnosis and treatment, more patients will experience CIPN despite completing cancer treatment, which interferes with recovery, leading to chronic pain and worsening quality of life. The National Cancer Institute has identified CIPN as a priority in translational research. To date, there are no FDA-approved drugs for preventing or treating CIPN, with emerging debate on mechanisms and promising new targets. This review highlights current literature and suggests novel approaches to CIPN based on proposed mechanisms of action that aim either to confer neuroprotection against chemotherapy-induced neurotoxicity or reverse the downstream effects of painful neuropathy. More... »

PAGES

1-13

References to SciGraph publications

  • 2010-05-25. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA in SUPPORTIVE CARE IN CANCER
  • 2017-02-10. Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? in SCIENTIFIC REPORTS
  • 2020-10-27. Status of peripheral sodium channel blockers for non-addictive pain treatment in NATURE REVIEWS NEUROLOGY
  • 2020-12-14. Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation in SCIENTIFIC REPORTS
  • 2019-05-24. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain in DRUGS
  • 2020-12-02. Neurotensin pathway in digestive cancers and clinical applications: an overview in CELL DEATH & DISEASE
  • 2002-01. Chemotherapy-induced peripheral neuropathy in JOURNAL OF NEUROLOGY
  • 2017-08-29. Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug in SCIENTIFIC REPORTS
  • 2005-08. Agonistic Properties of Cannabidiol at 5-HT1a Receptors in NEUROCHEMICAL RESEARCH
  • 1997-11. Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2019-05-10. Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity in JOURNAL OF MOLECULAR NEUROSCIENCE
  • 2020-05-11. Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy in PHARMACOLOGICAL REPORTS
  • 2020-03-09. Programmed axon degeneration: from mouse to mechanism to medicine in NATURE REVIEWS NEUROSCIENCE
  • 2017-09-18. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial in NEUROTHERAPEUTICS
  • 2015-06-22. Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling in SCIENTIFIC REPORTS
  • 2019-04-29. Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia in MOLECULAR NEUROBIOLOGY
  • 2015-02-15. Cancer treatment-related neuropathic pain: proof of concept study with menthol—a TRPM8 agonist in SUPPORTIVE CARE IN CANCER
  • 2009-09-15. Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat in NEUROTOXICITY RESEARCH
  • 2019-01-04. High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies in SUPPORTIVE CARE IN CANCER
  • 2007-08. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics in NATURE REVIEWS DRUG DISCOVERY
  • 2006-02-18. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors in NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY
  • 2019-08-13. DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain in SCIENTIFIC REPORTS
  • 2017-12-14. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial in SUPPORTIVE CARE IN CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13311-021-01142-2

    DOI

    http://dx.doi.org/10.1007/s13311-021-01142-2

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1142048338

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/34676514


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA", 
              "id": "http://www.grid.ac/institutes/grid.254444.7", 
              "name": [
                "Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bae", 
            "givenName": "Esther H.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Karmanos Cancer Institute, Detroit, MI, USA", 
              "id": "http://www.grid.ac/institutes/grid.477517.7", 
              "name": [
                "Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA", 
                "Karmanos Cancer Institute, Detroit, MI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Greenwald", 
            "givenName": "Mark K.", 
            "id": "sg:person.0716526470.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716526470.85"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Karmanos Cancer Institute, Detroit, MI, USA", 
              "id": "http://www.grid.ac/institutes/grid.477517.7", 
              "name": [
                "Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA", 
                "Karmanos Cancer Institute, Detroit, MI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schwartz", 
            "givenName": "Ann G.", 
            "id": "sg:person.015310443707.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015310443707.61"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/pl00007853", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053351904", 
              "https://doi.org/10.1007/pl00007853"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13311-017-0572-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091835196", 
              "https://doi.org/10.1007/s13311-017-0572-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41419-020-03245-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1132950735", 
              "https://doi.org/10.1038/s41419-020-03245-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00520-015-2642-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050667684", 
              "https://doi.org/10.1007/s00520-015-2642-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41598-019-48231-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1120279890", 
              "https://doi.org/10.1038/s41598-019-48231-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41582-020-00415-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1132044155", 
              "https://doi.org/10.1038/s41582-020-00415-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep11541", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033546161", 
              "https://doi.org/10.1038/srep11541"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41583-020-0269-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1125493056", 
              "https://doi.org/10.1038/s41583-020-0269-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12031-019-01321-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1114036392", 
              "https://doi.org/10.1007/s12031-019-01321-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41598-017-08891-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091313364", 
              "https://doi.org/10.1038/s41598-017-08891-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00520-017-4013-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1099701868", 
              "https://doi.org/10.1007/s00520-017-4013-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep42021", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083739305", 
              "https://doi.org/10.1038/srep42021"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00210-006-0033-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033258093", 
              "https://doi.org/10.1007/s00210-006-0033-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00520-018-4618-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1111097750", 
              "https://doi.org/10.1007/s00520-018-4618-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd2222", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051868416", 
              "https://doi.org/10.1038/nrd2222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00520-010-0911-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018082768", 
              "https://doi.org/10.1007/s00520-010-0911-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41598-020-78896-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1133487492", 
              "https://doi.org/10.1038/s41598-020-78896-w"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s40265-019-01132-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1115645597", 
              "https://doi.org/10.1007/s40265-019-01132-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12035-019-1616-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1113808643", 
              "https://doi.org/10.1007/s12035-019-1616-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-005-6978-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036146098", 
              "https://doi.org/10.1007/s11064-005-6978-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12640-009-9114-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041695789", 
              "https://doi.org/10.1007/s12640-009-9114-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002800050723", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036685616", 
              "https://doi.org/10.1007/s002800050723"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s43440-020-00109-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1127518958", 
              "https://doi.org/10.1007/s43440-020-00109-y"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2021-10-21", 
        "datePublishedReg": "2021-10-21", 
        "description": "Chemotherapy-induced peripheral neuropathy (CIPN) is a serious and often persistent adverse consequence of certain chemotherapeutic agents. It is a major dose-limiting factor of many first-line chemotherapies, affecting 20\u201350% of patients at standard doses and nearly all patients at high doses. As cancer survivorship continues to increase with improvements in early diagnosis and treatment, more patients will experience CIPN despite completing cancer treatment, which interferes with recovery, leading to chronic pain and worsening quality of life. The National Cancer Institute has identified CIPN as a priority in translational research. To date, there are no FDA-approved drugs for preventing or treating CIPN, with emerging debate on mechanisms and promising new targets. This review highlights current literature and suggests novel approaches to CIPN based on proposed mechanisms of action that aim either to confer neuroprotection against chemotherapy-induced neurotoxicity or reverse the downstream effects of painful neuropathy.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s13311-021-01142-2", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1294839", 
            "issn": [
              "1933-7213", 
              "1878-7479"
            ], 
            "name": "Neurotherapeutics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }
        ], 
        "keywords": [
          "chemotherapy-induced peripheral neuropathy", 
          "major dose-limiting factor", 
          "first-line chemotherapy", 
          "chemotherapy-induced neurotoxicity", 
          "dose-limiting factor", 
          "certain chemotherapeutic agents", 
          "quality of life", 
          "National Cancer Institute", 
          "promising new target", 
          "mechanism of action", 
          "painful neuropathy", 
          "peripheral neuropathy", 
          "standard doses", 
          "more patients", 
          "chronic pain", 
          "early diagnosis", 
          "cancer survivorship", 
          "Cancer Institute", 
          "high doses", 
          "therapeutic avenues", 
          "chemotherapeutic agents", 
          "patients", 
          "cancer treatment", 
          "translational research", 
          "new targets", 
          "neuropathy", 
          "adverse consequences", 
          "current literature", 
          "doses", 
          "downstream effects", 
          "treatment", 
          "neuroprotection", 
          "pain", 
          "chemotherapy", 
          "neurotoxicity", 
          "diagnosis", 
          "drugs", 
          "FDA", 
          "mechanism", 
          "review", 
          "agents", 
          "survivorship", 
          "target", 
          "factors", 
          "recovery", 
          "life", 
          "Institute", 
          "action", 
          "date", 
          "effect", 
          "improvement", 
          "novel approach", 
          "literature", 
          "consequences", 
          "quality", 
          "priority", 
          "avenues", 
          "research", 
          "approach", 
          "debate", 
          "persistent adverse consequence"
        ], 
        "name": "Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues", 
        "pagination": "1-13", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1142048338"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13311-021-01142-2"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "34676514"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13311-021-01142-2", 
          "https://app.dimensions.ai/details/publication/pub.1142048338"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T19:01", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_919.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s13311-021-01142-2"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01142-2'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01142-2'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01142-2'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01142-2'


     

    This table displays all metadata directly associated to this object as RDF triples.

    226 TRIPLES      22 PREDICATES      108 URIs      77 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13311-021-01142-2 schema:about anzsrc-for:11
    2 anzsrc-for:1112
    3 schema:author N7a035b43b85f439e9813761fbfb6c03a
    4 schema:citation sg:pub.10.1007/pl00007853
    5 sg:pub.10.1007/s00210-006-0033-x
    6 sg:pub.10.1007/s002800050723
    7 sg:pub.10.1007/s00520-010-0911-0
    8 sg:pub.10.1007/s00520-015-2642-8
    9 sg:pub.10.1007/s00520-017-4013-0
    10 sg:pub.10.1007/s00520-018-4618-y
    11 sg:pub.10.1007/s11064-005-6978-1
    12 sg:pub.10.1007/s12031-019-01321-z
    13 sg:pub.10.1007/s12035-019-1616-0
    14 sg:pub.10.1007/s12640-009-9114-1
    15 sg:pub.10.1007/s13311-017-0572-5
    16 sg:pub.10.1007/s40265-019-01132-x
    17 sg:pub.10.1007/s43440-020-00109-y
    18 sg:pub.10.1038/nrd2222
    19 sg:pub.10.1038/s41419-020-03245-8
    20 sg:pub.10.1038/s41582-020-00415-2
    21 sg:pub.10.1038/s41583-020-0269-3
    22 sg:pub.10.1038/s41598-017-08891-1
    23 sg:pub.10.1038/s41598-019-48231-z
    24 sg:pub.10.1038/s41598-020-78896-w
    25 sg:pub.10.1038/srep11541
    26 sg:pub.10.1038/srep42021
    27 schema:datePublished 2021-10-21
    28 schema:datePublishedReg 2021-10-21
    29 schema:description Chemotherapy-induced peripheral neuropathy (CIPN) is a serious and often persistent adverse consequence of certain chemotherapeutic agents. It is a major dose-limiting factor of many first-line chemotherapies, affecting 20–50% of patients at standard doses and nearly all patients at high doses. As cancer survivorship continues to increase with improvements in early diagnosis and treatment, more patients will experience CIPN despite completing cancer treatment, which interferes with recovery, leading to chronic pain and worsening quality of life. The National Cancer Institute has identified CIPN as a priority in translational research. To date, there are no FDA-approved drugs for preventing or treating CIPN, with emerging debate on mechanisms and promising new targets. This review highlights current literature and suggests novel approaches to CIPN based on proposed mechanisms of action that aim either to confer neuroprotection against chemotherapy-induced neurotoxicity or reverse the downstream effects of painful neuropathy.
    30 schema:genre article
    31 schema:inLanguage en
    32 schema:isAccessibleForFree false
    33 schema:isPartOf sg:journal.1294839
    34 schema:keywords Cancer Institute
    35 FDA
    36 Institute
    37 National Cancer Institute
    38 action
    39 adverse consequences
    40 agents
    41 approach
    42 avenues
    43 cancer survivorship
    44 cancer treatment
    45 certain chemotherapeutic agents
    46 chemotherapeutic agents
    47 chemotherapy
    48 chemotherapy-induced neurotoxicity
    49 chemotherapy-induced peripheral neuropathy
    50 chronic pain
    51 consequences
    52 current literature
    53 date
    54 debate
    55 diagnosis
    56 dose-limiting factor
    57 doses
    58 downstream effects
    59 drugs
    60 early diagnosis
    61 effect
    62 factors
    63 first-line chemotherapy
    64 high doses
    65 improvement
    66 life
    67 literature
    68 major dose-limiting factor
    69 mechanism
    70 mechanism of action
    71 more patients
    72 neuropathy
    73 neuroprotection
    74 neurotoxicity
    75 new targets
    76 novel approach
    77 pain
    78 painful neuropathy
    79 patients
    80 peripheral neuropathy
    81 persistent adverse consequence
    82 priority
    83 promising new target
    84 quality
    85 quality of life
    86 recovery
    87 research
    88 review
    89 standard doses
    90 survivorship
    91 target
    92 therapeutic avenues
    93 translational research
    94 treatment
    95 schema:name Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues
    96 schema:pagination 1-13
    97 schema:productId N0eed7d23fb6f49148e1748e965d64a37
    98 N2a76c4d2b17b4b9684b11971f118ce5d
    99 Nd4ab46b59d18424daebf150e6d3b09b3
    100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142048338
    101 https://doi.org/10.1007/s13311-021-01142-2
    102 schema:sdDatePublished 2022-01-01T19:01
    103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    104 schema:sdPublisher N95cbc971fe274a44ad30e7ff1fc6ab97
    105 schema:url https://doi.org/10.1007/s13311-021-01142-2
    106 sgo:license sg:explorer/license/
    107 sgo:sdDataset articles
    108 rdf:type schema:ScholarlyArticle
    109 N0eed7d23fb6f49148e1748e965d64a37 schema:name dimensions_id
    110 schema:value pub.1142048338
    111 rdf:type schema:PropertyValue
    112 N2a76c4d2b17b4b9684b11971f118ce5d schema:name doi
    113 schema:value 10.1007/s13311-021-01142-2
    114 rdf:type schema:PropertyValue
    115 N55d4d532b0fe4b4d95b2d1161b28842a schema:affiliation grid-institutes:grid.254444.7
    116 schema:familyName Bae
    117 schema:givenName Esther H.
    118 rdf:type schema:Person
    119 N6f2fb59e707d449bb176769682e4a4e9 rdf:first sg:person.0716526470.85
    120 rdf:rest Naf8ccdfc09e94e548fbdc15233a841a4
    121 N7a035b43b85f439e9813761fbfb6c03a rdf:first N55d4d532b0fe4b4d95b2d1161b28842a
    122 rdf:rest N6f2fb59e707d449bb176769682e4a4e9
    123 N95cbc971fe274a44ad30e7ff1fc6ab97 schema:name Springer Nature - SN SciGraph project
    124 rdf:type schema:Organization
    125 Naf8ccdfc09e94e548fbdc15233a841a4 rdf:first sg:person.015310443707.61
    126 rdf:rest rdf:nil
    127 Nd4ab46b59d18424daebf150e6d3b09b3 schema:name pubmed_id
    128 schema:value 34676514
    129 rdf:type schema:PropertyValue
    130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    131 schema:name Medical and Health Sciences
    132 rdf:type schema:DefinedTerm
    133 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    134 schema:name Oncology and Carcinogenesis
    135 rdf:type schema:DefinedTerm
    136 sg:journal.1294839 schema:issn 1878-7479
    137 1933-7213
    138 schema:name Neurotherapeutics
    139 schema:publisher Springer Nature
    140 rdf:type schema:Periodical
    141 sg:person.015310443707.61 schema:affiliation grid-institutes:grid.477517.7
    142 schema:familyName Schwartz
    143 schema:givenName Ann G.
    144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015310443707.61
    145 rdf:type schema:Person
    146 sg:person.0716526470.85 schema:affiliation grid-institutes:grid.477517.7
    147 schema:familyName Greenwald
    148 schema:givenName Mark K.
    149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716526470.85
    150 rdf:type schema:Person
    151 sg:pub.10.1007/pl00007853 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053351904
    152 https://doi.org/10.1007/pl00007853
    153 rdf:type schema:CreativeWork
    154 sg:pub.10.1007/s00210-006-0033-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033258093
    155 https://doi.org/10.1007/s00210-006-0033-x
    156 rdf:type schema:CreativeWork
    157 sg:pub.10.1007/s002800050723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036685616
    158 https://doi.org/10.1007/s002800050723
    159 rdf:type schema:CreativeWork
    160 sg:pub.10.1007/s00520-010-0911-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018082768
    161 https://doi.org/10.1007/s00520-010-0911-0
    162 rdf:type schema:CreativeWork
    163 sg:pub.10.1007/s00520-015-2642-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050667684
    164 https://doi.org/10.1007/s00520-015-2642-8
    165 rdf:type schema:CreativeWork
    166 sg:pub.10.1007/s00520-017-4013-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099701868
    167 https://doi.org/10.1007/s00520-017-4013-0
    168 rdf:type schema:CreativeWork
    169 sg:pub.10.1007/s00520-018-4618-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1111097750
    170 https://doi.org/10.1007/s00520-018-4618-y
    171 rdf:type schema:CreativeWork
    172 sg:pub.10.1007/s11064-005-6978-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036146098
    173 https://doi.org/10.1007/s11064-005-6978-1
    174 rdf:type schema:CreativeWork
    175 sg:pub.10.1007/s12031-019-01321-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1114036392
    176 https://doi.org/10.1007/s12031-019-01321-z
    177 rdf:type schema:CreativeWork
    178 sg:pub.10.1007/s12035-019-1616-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113808643
    179 https://doi.org/10.1007/s12035-019-1616-0
    180 rdf:type schema:CreativeWork
    181 sg:pub.10.1007/s12640-009-9114-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041695789
    182 https://doi.org/10.1007/s12640-009-9114-1
    183 rdf:type schema:CreativeWork
    184 sg:pub.10.1007/s13311-017-0572-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091835196
    185 https://doi.org/10.1007/s13311-017-0572-5
    186 rdf:type schema:CreativeWork
    187 sg:pub.10.1007/s40265-019-01132-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1115645597
    188 https://doi.org/10.1007/s40265-019-01132-x
    189 rdf:type schema:CreativeWork
    190 sg:pub.10.1007/s43440-020-00109-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1127518958
    191 https://doi.org/10.1007/s43440-020-00109-y
    192 rdf:type schema:CreativeWork
    193 sg:pub.10.1038/nrd2222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051868416
    194 https://doi.org/10.1038/nrd2222
    195 rdf:type schema:CreativeWork
    196 sg:pub.10.1038/s41419-020-03245-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132950735
    197 https://doi.org/10.1038/s41419-020-03245-8
    198 rdf:type schema:CreativeWork
    199 sg:pub.10.1038/s41582-020-00415-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132044155
    200 https://doi.org/10.1038/s41582-020-00415-2
    201 rdf:type schema:CreativeWork
    202 sg:pub.10.1038/s41583-020-0269-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125493056
    203 https://doi.org/10.1038/s41583-020-0269-3
    204 rdf:type schema:CreativeWork
    205 sg:pub.10.1038/s41598-017-08891-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091313364
    206 https://doi.org/10.1038/s41598-017-08891-1
    207 rdf:type schema:CreativeWork
    208 sg:pub.10.1038/s41598-019-48231-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1120279890
    209 https://doi.org/10.1038/s41598-019-48231-z
    210 rdf:type schema:CreativeWork
    211 sg:pub.10.1038/s41598-020-78896-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1133487492
    212 https://doi.org/10.1038/s41598-020-78896-w
    213 rdf:type schema:CreativeWork
    214 sg:pub.10.1038/srep11541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033546161
    215 https://doi.org/10.1038/srep11541
    216 rdf:type schema:CreativeWork
    217 sg:pub.10.1038/srep42021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083739305
    218 https://doi.org/10.1038/srep42021
    219 rdf:type schema:CreativeWork
    220 grid-institutes:grid.254444.7 schema:alternateName Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA
    221 schema:name Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA
    222 rdf:type schema:Organization
    223 grid-institutes:grid.477517.7 schema:alternateName Karmanos Cancer Institute, Detroit, MI, USA
    224 schema:name Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Suite 2A, 48201, Detroit, MI, USA
    225 Karmanos Cancer Institute, Detroit, MI, USA
    226 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...